28
nanotimes
Companies Facts
Investor Relations & Corporate Communications, will support both the upcoming product launch of the company‘s EU approved therapy for the treatment of brain tumors and the further development of its Nano-Cancer®
tions. MagForce expects its Nano-Cancer®
therapy in additional cancer indica- therapy
will become available at several leading German cancer centers in the first quarter of 2011.
Dr. Christoph Rehfuess joins MagForce as Director of Intellectual Property; Dr. Dirk Kautz joins MagForce as Director of Business/Corporate Development and will support the Management Board in strategic planning; Kajo Wiest joins as Director of Finance & Controlling and brings with him more than 10 years of finance and controlling experience at Jerini AG; Stacy Wiedenmann joins the company as Director of Investor Relations & Corporate Communications.
Furthermore, MagForce has been selected as the 2010 recipient of the STEP award in the category product/technology. The business award, initiated by Infraserv Höchst and F.A.Z. Institute, both Germany, along with leading industry sponsors, was awarded for the fifth time this year.
http://www.magforce.com
T sec
he Motorola Solutions business of Motorola, Inc. (NYSE: MOT) has entered into an agree-
ment with Kopin Corporation (NASDAQ: KOPN) to develop a hands-free computer and communications headset. This new device category is a head-worn, mobile computer headset with full voice, audio and PC capabilities, leveraging Kopin‘s advanced system and micro-display technologies to create a virtual 15-inch monitor that supports simulation software, streaming video on-demand and other large-screen
Typical measurement system: >180 sec µsprint: 1 sec
10-10/11 :: October/November 2010
Advertisement
Too fast for a photo: the new µsprint
NanoFocus AG Lindnerstrasse 98 | 46149 Oberhausen Phone +49 (0) 208-62 000-0 | Fax +49 (0) 208-62 000
info@nanofocus.de |
www.nanofocus.de WKN: 540066 | ISIN: DE 0005400667
NF10030
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79